DWP-05195

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDWP-05195
Drug Alias NameTR-1DWP-05195
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A